Jevtana 60 MG/1.5 ML kit 1.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQU4C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,854
Award facts
- Contract value 100% obligated
- $18,854.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18.85K delivery order to AmerisourceBergen Drug Corp for the supply of Jevtana (cabazitaxel) 60 mg/1.5 mL kits on January 13, 2026, with an ultimate completion date of February 4, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Jevtana is a chemotherapy agent used in oncology treatment, reflecting the Defense Logistics Agency's broader mission to supply critical pharmaceutical products to military healthcare systems and Department of Defense medical facilities.
This delivery order is executed under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract with the DLA Troop Support Medical valued at up to $999.9 million through December 31, 2031. This prime IDC serves as the comprehensive vehicle for delivering pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs globally. AmerisourceBergen, as a major pharmaceutical distributor, is well-positioned within the federal supply chain to fulfill such specialized medical procurement needs for the Department of Defense and related healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FQU4C?
SPE2DR26FQU4C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FQU4C worth?
The government has obligated $18,854 on SPE2DR26FQU4C.
Is contract SPE2DR26FQU4C an order under another contract?
Yes. SPE2DR26FQU4C is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQU4C competed?
The extent of competition for SPE2DR26FQU4C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award